Evaluating the contribution of a new electronic logistics management information system on the availability of HIV, TB and Malaria commodities in public hospitals in Uganda
摘要
Effective management of HIV, TB, and malaria requires reliable access to essential medicines, which is still a significant challenge in low and middle-income countries. This study aimed to assess the effect of the National Medical Stores Client Self-Service Portal (NMS + CSSP) on the availability of essential medicines and health supplies (EMHS) in public hospitals in Uganda. Specifically, it evaluated the system’s impact on ordering, reporting, and availability of HIV, TB, and malaria commodities.
MethodsA retrospective pre-post study design was used, involving 54 public hospitals across Uganda. Quantitative secondary data was collected from stock management records, including stock cards, delivery notes, and previous orders for three fiscal years spanning the pre- (FY 2020-21) and post-implementation periods (FY 2021-22 and FY 2022-23) using a specially designed data collection tool. Data on ordering and delivery frequency, order fill rates, ordering timeliness, delivery timeliness, monthly availability, and stock-out days of selected commodities were analyzed. Statistical analyses, including ANOVA and post hoc multiple comparison tests, were conducted to assess the difference in means of the variables.
ResultsThe overall order fill rate of HIV, TB, and malaria commodities increased from 72.6 to 81.4% (P = 0.003), ordering timeliness from 87.6 to 96.9% (P < 0.001), and delivery timeliness from 69.6 to 80.3% (P < 0.001) from FY 2020-21 to FY 2022-23, respectively. The availability of TDF/3TC/DTG 300 mg/300 mg/50 mg increased from 90.5 to 96.4% (P = 0.034), Tenofovir/Lamivudine 300/300 mg from 89.5 to 95.7% (P = 0.042), RHZE 150/75/400/275 mg from 90.5 to 96.4% (P = 0.031), RHZ 75 mg/50 mg/150 mg from 83.8 to 91.5% (P = 0.04), and Artemether/Lumefantrine 20/120 mg from 91 to 96.9% (P = 0.037) from FY 2020-21 to FY 2022-23, respectively. There was a significant reduction in stock-out days for TDF/3TC/DTG 300 mg/300 mg/50 mg from 20.4 to 14.5 days (P = 0.027), Tenofovir/Lamivudine 300/300 mg from 33.1 to 8.2 days (P = 0.035), and Artemether/Lumefantrine 20/120 mg from 25.0 to 10.4 days (P = 0.031).
ConclusionThis study showed improvement in ordering and delivery of HIV, TB, and malaria commodities following the introduction of NMS + CSSP, ultimately resulting in better availability and reduced stock-outs. These improvements suggest that robust electronic logistics management systems can enhance supply chain performance in resource-limited settings. Future research should explore the inclusion of lower-level health facilities to enhance generalizability and further optimize the benefits of electronic logistics management information systems.